Cargando…
LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
The prevalence and mortality rates of cardiovascular diseases are increasing, and new treatment strategies are urgently needed. From the perspective of basic pathogenesis, the occurrence and development of cardiovascular diseases are related to inflammation, apoptosis, fibrosis and autophagy of card...
Autores principales: | Li, Zining, Gao, Jialiang, Sun, Di, Jiao, Qian, Ma, Jing, Cui, Weilu, Lou, Yuqing, Xu, Fan, Li, Shanshan, Li, Haixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744949/ https://www.ncbi.nlm.nih.gov/pubmed/36523500 http://dx.doi.org/10.3389/fphar.2022.1045501 |
Ejemplares similares
-
LncRNA POU3F3 promotes melanoma cell proliferation by downregulating lncRNA MEG3
por: Liu, Yingnan, et al.
Publicado: (2021) -
Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
por: Ma, Chao, et al.
Publicado: (2023) -
Molecular Characterization and Biological Function of a Novel LncRNA CRNG in Swine
por: Lu, Qirong, et al.
Publicado: (2019) -
Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells
por: Li, Hongchang, et al.
Publicado: (2020) -
APOE-mediated suppression of the lncRNA MEG3 protects human cardiovascular cells from chronic inflammation
por: Zhao, Hongkai, et al.
Publicado: (2023)